Enlivex

ENLVNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.114 M

$0.69 -14.11%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

$1.24B

#332 by earnings

Shares outstanding

237,381,498

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#419ScientureSCNX$12.5M
#420Aspire BiopharmaASBP$12.2M
#421EnlivexENLV$12.1M
#422BioLineRxBLRX$12.0M
#423Kiora PharmaceuticalsKPRX$11.9M

What if Enlivex were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,731,384

Per share 2,499,111× higher

Bitcoin $1.72T

$98,356.21

Per share 141,969× higher

Nvidia $5.48T

$313,395.10

Per share 452,360× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Enlivex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.